Press Releases | Medtronic

Month Year

Email alerts

Aug 28, 2014

Covidien Acquires Venous Disease Treatment Developer Sapheon, Inc.

Transaction expands Covidien’s market leading portfolio with next generation technology for treatment of varicose veins

DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 28, 2014-- Covidien plc (NYSE: COV) today announced that it has acquired Sapheon, Inc., a privately-held developer of venous disease treatments. Financial...
Aug 28, 2014

Medtronic Receives Clearance for the SHILLA(TM) Growth Guidance System

First U.S. Growth Guidance System Cleared to Treat Scoliosis with Children's Needs in Mind

MEMPHIS, TN - Aug. 28, 2014 - Medtronic, Inc. (NYSE: MDT), today announced the 510(k) clearance and launch of the SHILLA(TM) Growth Guidance System. The system is designed for treatment of...
Aug 27, 2014

Medtronic Acquires NGC Medical to Strengthen Its Integrated Health Solutions Portfolio

NGC's Hospital Managed Services Business Adds to Medtronic's Growing Healthcare Services and Solutions Portfolio

TOLOCHENAZ - August 27, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has completed the acquisition of NGC Medical S.p.A. (NGC), a privately-held Italian company, in a transaction...
Aug 27, 2014

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Post-Market Clinical Trial Will Assess Superiority of the AdaptivCRT® Feature Compared to Standard CRT

MINNEAPOLIS - Aug. 27, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the first implants in a clinical trial that will compare patient and healthcare system outcomes - including patient...
Aug 26, 2014

Medtronic Acquires Sapiens Steering Brain Stimulation

Sapiens' Deep Brain Stimulation Technologies Strengthen Medtronic's Neuromodulation Portfolio and Neuroscience Leadership Position

MINNEAPOLIS and EINDHOVEN - Aug. 26, 2014 - Medtronic, Inc. (NYSE: MDT) today announced that it has acquired Sapiens Steering Brain Stimulation (Sapiens SBS), a privately held developer of deep...
Aug 26, 2014

Announcement under Irish Takeover Rules Relevant Securities in Issue – August 26, 2014

DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 26, 2014-- In accordance with Rule 2.10 of the Irish Takeover Rules, Covidien plc (NYSE: COV) (the “Company”) confirms that, as of the close of business...
Aug 25, 2014

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

AdaptivCRT® Algorithm Customizes Therapy for Heart Failure Patients and Improves Their Response Rates

MINNEAPOLIS - Aug. 25, 2014 - Medtronic, Inc. (NYSE:MDT) today announced the U.S. Food and Drug Administration (FDA) approval of its newest cardiac resynchronization therapy-pacemaker, Viva®...
Aug 22, 2014

Covidien Acquires Reverse Medical Corporation

Generates Opportunity to Leverage Existing Vascular Technologies and Customer Relationships to Drive Increased Market Penetration

DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 22, 2014-- Covidien plc (NYSE:COV) today announced it has acquired Reverse Medical Corporation, a privately held medical device company focused on expanding...
Aug 21, 2014

Medtronic Announces Cash Dividend for Second Quarter of Fiscal Year 2015

MINNEAPOLIS - August 21, 2014 - The board of directors of Medtronic, Inc. (NYSE:MDT) today approved a cash dividend of $0.305 per share of the company's common stock. The quarterly dividend...
Aug 21, 2014

FDA Approves Changes to Manufacturing Process for Covidien’s Pipeline™ Embolization Device

DUBLIN, Ireland--(BUSINESS WIRE)--Aug. 21, 2014-- Covidien plc (NYSE: COV) today announced that the U.S. Food and Drug Administration (FDA) has approved changes to the manufacturing process for...

Show per page